Semaglutide

Semaglutide is a 31-residue GLP-1 receptor agonist analogue in which the lysine at position 26 of native GLP-1 is acylated with a C18 fatty diacid via a γGlu-2xOEG linker. Substitution of Ala8 with α-aminoisobutyric acid (Aib) confers DPP-4 resistance; the lipid moiety enables high-affinity albumin binding and an extended plasma half-life in primate models.

• Semaglutide Structure and Synthesis for Laboratory Use
• How to Evaluate Semaglutide COAs: HPLC and Mass Spectrometry Explained
• Semaglutide Stability, Solubility and Storage for Research
• Semaglutide vs Retatrutide – Research Comparison
• Semaglutide Key Preclinical Research Findings Summary
• Semaglutide Analytical Testing Methods: Deep Dive

≥99% purity, third-party COA verified, manufactured in the USA. For research use only — not for human or veterinary use.